|
Name |
5,8-dihydroxy-10-methoxy-2-methyl-4H-benzo[h]chromen-4-one
|
Molecular Formula | C15H12O5 | |
IUPAC Name* |
4,5-dihydroxy-10-methoxy-2-methylbenzo[h]chromen-8-one
|
|
SMILES |
CC1=CC(=C2C(=CC3=CC(=O)C=C(C3=C2O1)OC)O)O
|
|
InChI |
InChI=1S/C15H12O5/c1-7-3-10(17)14-11(18)5-8-4-9(16)6-12(19-2)13(8)15(14)20-7/h3-6,17-18H,1-2H3
|
|
InChIKey |
NSAPXJZXVFHIHJ-UHFFFAOYSA-N
|
|
Synonyms |
TMC-256C1; CHEMBL454794; SCHEMBL15060672; TMC 256C1; BDBM50242177; 5,8-dihydroxy-10-methoxy-2-methyl-benzo[h]chromen-4-one; 5,8-dihydroxy-10-methoxy-2-methyl-4H-benzo[h]chromen-4-one; 5,8-dihydroxy-10-methoxy-2-propyl-4H-benzo[h]chromen-4-one
|
|
CAS | NA | |
PubChem CID | 135418331 | |
ChEMBL ID | CHEMBL454794 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 272.25 | ALogp: | 0.7 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 20 | QED Weighted: | 0.663 |
Caco-2 Permeability: | -4.869 | MDCK Permeability: | 0.00000843 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.698 |
Human Intestinal Absorption (HIA): | 0.029 | 20% Bioavailability (F20%): | 0.013 |
30% Bioavailability (F30%): | 0.964 |
Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 86.75% |
Volume Distribution (VD): | 0.79 | Fu: | 12.45% |
CYP1A2-inhibitor: | 0.976 | CYP1A2-substrate: | 0.963 |
CYP2C19-inhibitor: | 0.163 | CYP2C19-substrate: | 0.096 |
CYP2C9-inhibitor: | 0.536 | CYP2C9-substrate: | 0.864 |
CYP2D6-inhibitor: | 0.628 | CYP2D6-substrate: | 0.574 |
CYP3A4-inhibitor: | 0.252 | CYP3A4-substrate: | 0.172 |
Clearance (CL): | 9.957 | Half-life (T1/2): | 0.743 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.08 |
Drug-inuced Liver Injury (DILI): | 0.96 | AMES Toxicity: | 0.653 |
Rat Oral Acute Toxicity: | 0.11 | Maximum Recommended Daily Dose: | 0.912 |
Skin Sensitization: | 0.873 | Carcinogencity: | 0.09 |
Eye Corrosion: | 0.052 | Eye Irritation: | 0.936 |
Respiratory Toxicity: | 0.528 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001770 | 0.662 | D06GCK | 0.363 | ||||
ENC003794 | 0.518 | D07MGA | 0.349 | ||||
ENC002523 | 0.507 | D04AIT | 0.345 | ||||
ENC000962 | 0.507 | D0FA2O | 0.342 | ||||
ENC006014 | 0.500 | D0G4KG | 0.333 | ||||
ENC002113 | 0.477 | D0K8KX | 0.322 | ||||
ENC001631 | 0.474 | D0AZ8C | 0.264 | ||||
ENC005649 | 0.474 | D08SKH | 0.263 | ||||
ENC005191 | 0.467 | D0E9CD | 0.250 | ||||
ENC001653 | 0.467 | D0D4HN | 0.250 |